MedTrace Logo

Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention

NCT02498431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2017-01-18

No results posted yet for this study

Summary

The investigators aim to evaluate circulating irisin levels alterations in patients with acute myocardial infraction and in patients with coronary artery disease subjected to percutaneous coronary intervention.

Conditions

Interventions

PROCEDURE

percutaneous coronary intervention

a non-surgical procedure used to treat the stenotic (narrowed) coronary arteries of the heart found in coronary heart disease

PROCEDURE

coronary angiography

is a procedure performed along with cardiac catheterization that uses X-ray imaging to see your heart's blood vessels

DEVICE

Stent, Medronic Resolute Integrity

A stent is placed in an artery as part of a procedure called percutaneous coronary intervention (PCI) to restore blood flow through narrow or blocked arteries. A stent helps support the inner wall of the artery in the months or years after PCI.

Sponsors & Collaborators

  • 424 General Military Hospital

    lead OTHER

Principal Investigators

  • Athanasios D Anastasilakis, PhD · 424 General Military Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02498431 on ClinicalTrials.gov